Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Oct 16, 2025 · Filed Oct 20, 2025
The boss of Hims & Hers Health sold $2.47M of Hims & Hers Health shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,466,112
Shares × reported transaction price
73 days after results of Aug 4, 2025, 18 days before results of Nov 3, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −4.5% | +2.4% | −6.9% |
| 30 days | −31.9% | −2.8% | −29.1% |
| 90 days | −38.3% | +0.9% | −39.2% |
| 180 days | −37.2% | +5.6% | −42.8% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$853K of Hims & Hers Health
Scheduled in advance